Picture EBD Group World of Partnering Opportunities 650x100px

Financing › Details

Sensorion–SEVERAL: investment, 202402 reserved offering €50.5m with 88.6m new ordinary shares at €0.57/share to existing + new investors

	Period	2024-02-09 � 2024-02-13
	Money taker	Sensorion S.A. (Euronext Alternext: ALSEN)
	Money source	SEVERAL
	Product	SENS-501 gene therapy (OTOF-GT) (Sensorion)
	Product 2	investment banking
	Source	Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier.

Record changed: 2024-12-20

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Sensorion S.A. (Euronext Alternext: ALSEN)

[1] Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier....
[2] Sensorion S.A.. (1/19/24). "Press Release: Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries". Montpellier....
[3] Sensorion S.A.. (1/5/24). "Press Release: Sensorion Announces Partnership with the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years". Montpellier....
[4] Sensorion S.A.. (1/31/23). "Press Release: Sensorion and Eveon Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments into the Inner Ear". Montpellier....
[5] Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier....
[6] Sensorion S.A.. (5/27/19). "Press Release: Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss". Montpellier....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)